Details
Manufacturer:
SMB Technology S.A., Belgium
Registraction Number:
MAL12095052AZ
Content:
-
Each capsule contains Fenofibrate 160mg in Lidose form (improves absorption).
Indications:
-
Treatment of primary hypercholesterolemia or mixed dyslipidemia (Types IIa, IIb, III, IV, V) in adults not responsive to dietary measures alone.
-
Management of secondary hyperlipidemia, including lipid disorders associated with diabetes mellitus.
Instructions :
-
Take one 160mg capsule once daily, with food.
-
Swallow whole; do not crush or chew the capsule.
-
Continue with a low-fat, low-cholesterol diet during treatment.
View more about Fenosup 160mg on main site